Navigation Links
Recalled ICD leads fail in women, youths most often
Date:1/31/2011

The recalled Sprint Fidelis implantable cardioverter-defibrillator (ICD) leads (Medtronic) failed more often in younger patients, women, and individuals with hereditary heart disease, according to a multicenter study published online Jan. 17 in Circulation. The researchers found that lead failure was not associated with death or serious injuries.

However, about half of the patients whose leads fractured experienced painful inappropriate shocks, according to lead author Robert G. Hauser, MD, of the Minneapolis Heart Institute at Abbott Northwestern Hospital. In a previous study, published in HeartRhythm in 2010, Hauser and colleagues found these inappropriate shocks could be mitigated by a software program available in Medtronic ICDs.

The manufacturer voluntarily removed Sprint Fidelis leads from the market in 2007 after 268,000 were implanted globally. Currently, more than 100,000 patients have Fidelis leads.

In this observational study, 1,023 Fidelis and 1,668 Quattro leads were implanted and followed at three centers (Minneapolis Heart Institute in Minneapolis, Mayo Clinic in Rochester, Minn., and Beth Israel Deaconess Medical Center in Boston) from November 2001 to January 2009

"We were particularly interested in whether Fidelis leads were continuing to fail, in whom they were failing and what the implications might be for those patients," Hauser says. "We found that patients who were young and active with relatively normal pump function were at highest risk, as well as women compared with men."

The researchers found the failure rate for Fidelis leads was 2.81 percent per year, compared with 0.43 percent per year for Quattro Secure leads, also manufactured by Medtronic.. The authors described the Quattro failure rate as being "well below the suggested benchmark of 0.6 percent per year. The survival of Fidelis leads at four years was 87 percent, compared with 98.7 percent for Quattro leads

These findings could have significant implications for the management of patients who have Fidelis leads. While Fidelis continue to fail, Hauser and his colleagues conclude that there is currently no indication for arbitrarily replacing leads in patients who were indicated for ICDs, particularly due to the potential risk with the replacement procedures.

"Only in the hands of experienced operators should Fidelis lead replacement even be considered in these younger patients or women, who are expected to live with an ICD for a number of years," Hauser stresses.


'/>"/>

Contact: Meghan Bethke
mbethke@mhif.org
612-863-5410
Minneapolis Heart Institute Foundation
Source:Eurekalert

Related medicine news :

1. FDA Found Bacteria in Ingredients for Recalled Tylenol, Benadryl
2. Learning Lab of Brentwood Leads Free ADHD Seminar
3. Human Dental Technology Leads to Breakthroughs for Pet Dental Health at Sergeants Pet Care Products, Inc.
4. TechCFO Enters Mid-Atlantic Market; Rick Rolandi Leads DC Metro Office
5. Home Health Agency Owner Pleads Guilty in Connection with Detroit Fraud Scheme
6. New DNA technique leads to a breakthrough in child cancer research
7. AGA leads the way in GI innovation
8. Arsenic exposure activates an oncogenic signaling pathway; leads to increased cancer risk
9. KV Pharmaceutical Subsidiary Pleads Guilty to Two Felonies Regarding Oversized Drugs
10. China's Forbidden City Leads Landmark Climate Action for Earth Hour
11. McMaster researcher leads development of promising drug for inflammation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 2016 , ... Gout is like no other joint pain. It strikes suddenly, ... intense swelling and redness. It is triggered by the crystallization of uric acid within ... most susceptible, according to the February 2016 issue of Harvard Men's Health Watch. , ...
(Date:2/10/2016)... MI (PRWEB) , ... February 10, 2016 , ... ... Apifiny® across their network of laboratory service centers across the country. Launched ... to aid clinicians in the detection of prostate cancer. Apifiny order volume exceeded 3,000 ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric therapists are challenged ... Research shows that the Goal Attainment Scale (GAS) captures 20% more change in ... learn more about the Goal Attainment Scale, Education Resources Inc. is offering a ...
(Date:2/10/2016)... , ... February 10, 2016 , ... ... will attend the Ohio Safety Congress and Expo event March 9-11, 2016. Hosted ... Greater Columbus Convention Center. , As the longest running and largest worker's ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... Everseat digital self-scheduling readily available to physicians. The integration will enable Allscripts ... and select appointments via Everseat’s free mobile app. , The partnership gives Everseat ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... PUNE, India , February 10, 2016 ... to a new market research report "Pharmaceutical Packaging Equipment ... Packaging, Wrapping, Labeling & Serialization), by Product Type (Tablet, ... to 2020", published by MarketsandMarkets, studies the global market during ... is expected to grow at a CAGR of 6.9% ...
(Date:2/10/2016)... February 10, 2016 ... Targeted Therapeutics and Companion Diagnostic Market to 2019 ... and Environment" research report indicates that the core ... billion by 2020 growing at a CAGR of ... diagnostics and targeted therapeutics and is dominated by ...
(Date:2/9/2016)...  Misonix, Inc. (NASDAQ: MSON ), an ... markets innovative therapeutic ultrasonic products for spine surgery, ... surgery and other surgical applications, today announced financial ... half of fiscal year 2016 ended December 31, ... --> Highlights for the second quarter and ...
Breaking Medicine Technology: